管理心血管危险因素：女性的试验证据。

Managing cardiovascular risk factors: trial evidence in women.

机构信息

AstraZeneca LP, 1800 Concord Pike, PO Box 15437, Wilmington, DE 19850-5437, USA.

出版信息

Nutr Metab Cardiovasc Dis. 2010 Jul;20(6):445-50. doi: 10.1016/j.numecd.2010.01.010. Epub 2010 Apr 13.

DOI:10.1016/j.numecd.2010.01.010

PMID:20392615

Abstract

Cardiovascular disease remains by far the leading cause of death for women worldwide. Despite a large body of research identifying effective interventions to reduce cardiovascular risk, translation into practice has been slow. This review pinpoints areas in particular need of improvement and summarizes gender-specific analyses in recent randomized trials assessing the impact of risk factor modulation on cardiovascular events.

摘要

心血管疾病仍然是目前全球女性死亡的主要原因。尽管有大量研究确定了有效干预措施来降低心血管风险，但这些干预措施在实践中的应用进展缓慢。本综述特别指出了需要改进的领域，并总结了最近评估危险因素调节对心血管事件影响的随机试验中的性别特异性分析。